Filing Flows › ICU Medical (ICUI) › Q3 2026 › vs Q2 2026
ICU Medical (ICUI) Q3 2026 vs Q2 2026 (quarter over quarter)
ICU Medical's revenue rose $8.8M (+2%) from $552M in Q2 2026 to $560M in Q3 2026. The biggest changes: Infusion Consumables +$9.1M (+3%); Vital Care −$3.9M (-5%); Infusion Systems +$3.5M (+2%). Gross margin 41.9% against 42.6% (-0.7 pts).
ICU Medical, Q3 2026: revenue $560M (+4% year over year), operating margin 9.3%, net earnings $26.8M, operating cash flow $99.6M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Gross margin | 41.9% | 42.6% | -0.7 pts |
| Operating margin | 9.3% | 7.1% | +2.2 pts |
| Net margin | 4.8% | 3.5% | +1.3 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Infusion Consumables | $298M | $289M | $9.1M | +3% |
| Infusion Systems | $193M | $189M | $3.5M | +2% |
| Vital Care | $69.5M | $73.4M | −$3.9M | -5% |
| Revenue | $560M | $552M | $8.8M | +2% |
| Gross profit | $235M | $235M | −$299K | -0.1% |
| Cost of revenue | $326M | $317M | $9.1M | +3% |
| Operating profit | $52.3M | $39.1M | $13.2M | +34% |
| Operating expenses | $182M | $196M | −$13.5M | -7% |
| Pre-tax earnings | $34.0M | $26.2M | $7.9M | +30% |
| Other expense, net | $18.3M | $13.0M | $5.3M | +41% |
| Research & development | $21.8M | $22.7M | −$948K | -4% |
| SG&A | $154M | $152M | $2.5M | +2% |
| Other operating costs | $6.3M | $21.3M | −$15.0M | -71% |
| Net earnings | $26.8M | $19.1M | $7.8M | +41% |
| Income tax | $7.2M | $7.1M | $123K | +2% |
| Depreciation & amortization | $49.6M | $49.6M | −$19K | 0% |
| Share-based compensation | $11.9M | $11.9M | −$7K | -0.1% |
| Working capital & other | $11.3M | −$420K | $11.7M | — |
| Operating cash flow | $99.6M | $80.2M | $19.4M | +24% |
Questions
How much did ICU Medical's revenue grow quarter over quarter in Q3 2026?
ICU Medical's revenue rose $8.8M (+2%) from $552M in Q2 2026 to $560M in Q3 2026.
What drove ICU Medical's revenue change in Q3 2026?
Infusion Consumables +$9.1M (+3%); Vital Care −$3.9M (-5%); Infusion Systems +$3.5M (+2%).